Dizziness, a common symptom in clinical practice, often presents a diagnostic challenge due to its multifaceted nature. Vertigo, a subtype of dizziness, is characterized by a sensation of self-motion or environmental motion, and is often associated with balance disorders. This article offers a comprehensive clinical approach to vertigo, aiding healthcare professionals in accurate diagnosis and effective management.
Vertigo is frequently a symptom of vestibular dysfunction, often resulting from conditions such as benign paroxysmal positional vertigo (BPPV), Meniere's disease, or vestibular neuritis. Differentiating between central and peripheral causes of vertigo is crucial, as the latter are generally benign while the former may signal serious neurological conditions.
A thorough history and physical examination are essential in evaluating a patient with vertigo. Key elements include the duration and frequency of episodes, associated symptoms such as tinnitus or hearing loss, and triggers. Physical examination should include a neuro-otological examination, and tests like the Dix-Hallpike maneuver or head impulse test can be useful in diagnosis.
Management of vertigo should be tailored to the underlying cause. BPPV, for instance, can be treated with canalith repositioning maneuvers, while Meniere's disease may require dietary modifications, diuretics, or even surgery in refractory cases. Vestibular rehabilitation therapy can be beneficial for patients with chronic vertigo.
Vertigo, though common, can be a complex clinical entity to manage. A systematic approach to assessment, along with a clear understanding of the underlying pathophysiology, can guide effective management strategies. As healthcare professionals, we must stay abreast of the latest evidence-based practices to provide optimal care for our patients experiencing vertigo.
1.
Research discovery halts childhood brain tumor before it forms
2.
Increased Data Support Active Monitoring for Low-Risk Prostate Cancer.
3.
'CDC Must Be Investigated'; David Lynch, Bob Uecker Die; Nasal Epinephrine Warning
4.
Increasing Access to Prostate Cancer Drugs; Reducing Toxic Emissions; FTC Files a 'Charity' Suit.
5.
Infections the Main Cause of Nonrelapse Mortality After CAR-T for Blood Cancers
1.
Beyond the Blinders: A Review of Targeted Therapeutic Strategies for Triple-Negative Breast Cancer in 2025
2.
AI-Based Cancer Follow-Up Monitoring: Transforming Survivorship Care through Intelligent Surveillance
3.
Preventing Sarcopenia During Cancer Treatment
4.
Guidance for Managing Complex Anticoagulation
5.
Unlocking the Potential of Sarclisa: A New Hope for Cancer Treatment
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Updates on Standard V/S High Risk Myeloma Treatment
2.
Navigating the Complexities of Ph Negative ALL - Part XIV
3.
Current Scenario of Blood Cancer- A Conclusion on Genomic Testing & Advancement in Diagnosis and Treatment
4.
Advances in Classification/ Risk Stratification of Plasma Cell Dyscrasias
5.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part I
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation